Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1373–1380. doi: 10.1158/1055-9965.EPI-09-1282

Table 4.

Multivariate association of risk factors for VIA positivity (n = 2,288)

Variable OR (95% CI) Adj. OR (95% CI)
Age (y)
  25–29 1 1
  30–59 1.33 (0.99–1.79) 1.13 (0.83–1.55)
  60+ 2.92 (1.83–4.65) 2.08 (1.25–3.47)
Pap outcome*
  Negative 1 1
  Positive 1.32 (1.04–1.70) 1.41 (1.00–1.98)
Cervical inflammation
  Absent 1 1
  Present 2.86 (2.21–3.70) 4.3 (3.16–5.86)
Gynecologist
  1 1 1
  4 3.85 (2.43–6.10) 2.59 (1.61–4.16)
  5 11.23 (6.99–18.02) 13.79 (8.43–22.57)
  6 5.37 (3.22–8.96) 6.13 (3.62–10.38)
  7 2.62 (1.46–4.71) 2.13 (1.17–3.89)
  8 1.06 (0.40–2.83) 1.04 (0.39–2.83)

NOTE: Data were mutually adjusted for all the variables in the model; 43 dropped due to missing data.

Abbreviations: OR, odds ratio; 95% CI, 95% confidence interval.

*

Pap smear negative, normal/reactive atypia; positive, ASC-US or more severe diagnosis.

Cervical inflammation indicates erythema, edema, or bleeds on contact.

Gynecologist no. 3 saw <10 patients, none of whom were VIA positive, and was therefore excluded from this analysis.